Drug maker Biocon will report its first quarter numbers of FY13 today. Analysts on an average expect the profit after tax to grow by 25% to Rs 88 crore from Rs 70 crore year-on-year.
first published: Jul 25, 2012 10:17 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

